factor Bb | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

14,149 results for “factor Bb”

Trials

View all 9564 →

Efficacy of PRF Application on Clinical Parameters and GCF Platelet-derived Growth Factor-BB and Periostin Levels

14 participants · First posted Jan 5, 2022

A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults

54 participants · First posted Mar 22, 2024

Becaplermin Gel for MARTORELL's Hypertensive Leg Ulcers

64 participants · First posted Sep 2, 2009

Drugs

View all 1101 →

AAV vector expressing anti-aC1s/anti-factor Bb scFabs (geographic atrophy)

Becaplermin(Regranex)

Conditions: Skin Ulcer

BB-102

Organizations

View all 295 →

BB Biotech

Switzerland

BB MEDICAL & DERMATOLOGY INC

United States

MAGNESIUM FACTOR PTY LTD

Australia

News

View all 3189 →

Sanofi's SAR446597 Gene Therapy Receives FDA Fast Track Designation for Geographic Atrophy Treatment

Lynch Regenerative Medicine Completes Enrollment in Phase II Trial of rhPDGF-BB for Full-Thickness Head and Neck Wound Healing

Complement-Based Drug Development Gains Momentum Following FDA Approvals and Pipeline Advances

Page 1 of 1415